K010236 is an FDA 510(k) clearance for the IMMAGE IMMUNOCHEMISTRY SYSTEM HIGH SENSITIVITY C-REACTIVE PROTEIN (CRPH) REAGENT. This device is classified as a C-reactive Protein, Antigen, Antiserum, And Control (Class II - Special Controls, product code DCK).
Submitted by Beckman Coulter, Inc. (Brea, US). The FDA issued a Cleared decision on April 5, 2001, 70 days after receiving the submission on January 25, 2001.
This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5270.